Related Experiment Video
Updated: Aug 12, 2026
12:10
Performing Behavioral Tasks in Subjects with Intracranial Electrodes
Published on: October 2, 2014
Management of epilepsy in the elderly
1Texas Comprehensive Epilepsy Program, Department of Neurology, University of Texas Medical School, Houston 77030, USA.
Epilepsia
|January 1, 1996
Summary
Managing epilepsy in older adults requires understanding unique patient needs and potential drug interactions. Careful assessment and monitoring are crucial for effective treatment and minimizing side effects in this growing population.
Area of Science:
- Geriatrics
- Neurology
- Clinical Pharmacology
Background:
- Epilepsy prevalence is increasing in the elderly population globally.
- Aging affects physiological functions impacting drug metabolism and elimination.
- Elderly patients often have comorbidities and polypharmacy, complicating treatment.
Purpose of the Study:
- To highlight the unique challenges in managing epilepsy in elderly patients.
- To emphasize the need for tailored treatment strategies considering age-related factors.
- To guide healthcare providers in optimizing antiepileptic drug (AED) therapy for seniors.
Main Methods:
- Comprehensive assessment of seizures, etiology, and comorbidities.
- Evaluation of potential drug interactions due to polypharmacy.
- Consideration of age-related physiological changes in drug metabolism and elimination.
Main Results:
- Elderly patients are susceptible to central nervous system (CNS) side effects of AEDs.
- Concomitant medications can alter AED efficacy and adverse effect profiles.
- AEDs may induce metabolism of other drugs, reducing their effectiveness.
Conclusions:
- Optimal epilepsy management in the elderly necessitates individualized treatment plans.
- Close monitoring of AED concentrations (e.g., free levels) is recommended.
- Physician awareness of social factors and careful dose selection are vital for successful outcomes.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...